Delivery Order SPE2DB22D1017-SPE2DB25FE8XP

Award Date 11/8/24
Potential Completion Date 12/3/24
Potential Value $4.3K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was granted by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,293.36 firm fixed-price delivery order is for the supply of COMIRNATY (COVID-19 vaccine) for individuals 12 years and older, with a completion date of December 5, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,586.72 firm fixed-price delivery order is for the supply of COMIRNATY (COVID-19) vaccines for individuals aged 12 years and older, with an ultimate completion date of November 27, 2024. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,670.00 firm fixed-price delivery order is for the supply of COMIRNATY COVID-19 vaccines for individuals aged 12 and up, with a completion date of November 8, 2024. The contract represents a task order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of COMIRNATY (COVID-19) vaccines for individuals aged 12 and above. The Firm Fixed Price contract, valued at $1,467.00, was awarded on October 14, 2024 with a completion date of November 4, 2024. This award is likely part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,293.36, is for the delivery of COMIRNATY (COVID-19) vaccines for individuals aged 12 and up. The award is a firm fixed-price delivery order contract with a completion date of December 9, 2024. This contract is not associated with a set-aside designation. AmerisourceBergen holds a significant...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,961.16 fixed-price delivery order is for the procurement of COMIRNATY vaccines for individuals aged 12 and above, with a performance period through February 14, 2025. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical,...
This federal contract award, valued at $2,961.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY (COVID-19) vaccines for individuals 12 years and older, with a completion date of January 15, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $22,005 firm fixed-price delivery order is for the procurement of Comirnaty (COVID-19) vaccines for individuals 12 years and older, with a completion date of November 14, 2024. The contract is not designated with a set-aside and represents an open competition. AmerisourceBergen holds a substantial $999,999,999...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of COMIRNATY (COVID-19) vaccines for individuals aged 12 and above. The award, valued at $1,480.58, is for a firm fixed-price contract with a period of performance ending on January 10, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
This is a $6,045.02 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of COMIRNATY (COVID-19) vaccines for individuals aged 12 and up, with a completion date of January 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999...
  • SPE2DB22D1017
    Indefinite Delivery Contract
  • SPE2DB22D1017-SPE2DB25FE8XP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,293.36 firm fixed-price delivery order is for the supply of COMIRNATY (COVID-19) vaccines, specifically for individuals 12 years of age and older. The contract has an ultimate completion date of December 3, 2024. This award is a child under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. No set-aside designation was used for this specific contract award.

Generated 2/7/25, 9:10 AM